Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lawrence

Showing results (521-530 of 534) with videos related to

Pageof 54
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2014
Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitorDouglas B Johnson, Keith T Flaherty, Jeffrey S Weber, et al.
Fungal Systematics and Evolution|September 9, 2020
New and Interesting Fungi. 3P W Crous, M J Wingfield, R K Schumacher, et al.
The British Journal of Dermatology|March 16, 2022
Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational studyXue Bai, Alexander N Shoushtari, Allison Betof Warner, et al.
Nature Communications|October 27, 2017
Resistance to checkpoint blockade therapy through inactivation of antigen presentationMoshe Sade-Feldman, Yunxin J Jiao, Jonathan H Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 MonotherapyXue Bai, Jiani Hu, Allison Betof Warner, et al.
Science Immunology|April 24, 2026
Mitochondrial fission mediates an evolutionarily conserved antibacterial defense responseRonan Kapetanovic, Syeda Farhana Afroz, James E B Curson, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TILHongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Journal for Immunotherapy of Cancer|February 24, 2019
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitorsMagid Awadalla, Doll Lauren Alexandra Golden, Syed S Mahmood, et al.
Cell Reports. Medicine|March 4, 2022
Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanomaSamuel S Freeman, Moshe Sade-Feldman, Jaegil Kim, et al.
Journal of the American College of Cardiology|February 8, 2020
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related MyocarditisMagid Awadalla, Syed S Mahmood, John D Groarke, et al.
Pageof 54

Showing results (521-530 of 534) with videos related to

Sort By:
Pageof 54
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2014
Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitorDouglas B Johnson, Keith T Flaherty, Jeffrey S Weber, et al.
Fungal Systematics and Evolution|September 9, 2020
New and Interesting Fungi. 3P W Crous, M J Wingfield, R K Schumacher, et al.
The British Journal of Dermatology|March 16, 2022
Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational studyXue Bai, Alexander N Shoushtari, Allison Betof Warner, et al.
Nature Communications|October 27, 2017
Resistance to checkpoint blockade therapy through inactivation of antigen presentationMoshe Sade-Feldman, Yunxin J Jiao, Jonathan H Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 MonotherapyXue Bai, Jiani Hu, Allison Betof Warner, et al.
Science Immunology|April 24, 2026
Mitochondrial fission mediates an evolutionarily conserved antibacterial defense responseRonan Kapetanovic, Syeda Farhana Afroz, James E B Curson, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TILHongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Journal for Immunotherapy of Cancer|February 24, 2019
Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitorsMagid Awadalla, Doll Lauren Alexandra Golden, Syed S Mahmood, et al.
Cell Reports. Medicine|March 4, 2022
Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanomaSamuel S Freeman, Moshe Sade-Feldman, Jaegil Kim, et al.
Journal of the American College of Cardiology|February 8, 2020
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related MyocarditisMagid Awadalla, Syed S Mahmood, John D Groarke, et al.
Pageof 54